9 Best Indian Stocks to Buy According to Hedge Funds

7. Dr. Reddy’s Laboratories Limited (NYSE:RDY)

Number of Hedge Fund Holders: 10

Dr. Reddy’s Laboratories Limited (NYSE:RDY) is one of the Best Indian Stocks to Buy According to Hedge Funds. On March 21, the company announced the rollout of its injectable semaglutide under the brand name Obeda®. This demonstrates a critical step in the expansion of access to advanced GLP‑1 receptor agonist–based therapy for managing type 2 diabetes in India.

Dr. Reddy’s Laboratories Limited (NYSE:RDY) is the first Indian company to get the DCGI (Drugs Controller General of India) approval for generic semaglutide.

Dr. Reddy’s Laboratories Limited (NYSE:RDY), while quoting the ICMR‑INDIAB study, noted that India has one of the world’s largest diabetes burdens, as more than 101 million adults live with this condition. Semaglutide, which is a GLP‑1 receptor agonist, can improve glycaemic control and help with weight management if used as part of the comprehensive treatment plan. Given that API development, manufacturing, and formulation development occur in-house, Obeda® demonstrates Dr. Reddy’s Laboratories Limited (NYSE:RDY)’s strength in complex product development and peptide science.

Dr. Reddy’s Laboratories Limited (NYSE:RDY) operates as a pharmaceutical company.